Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.

Shenkier TN, Blay JY, O'Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJ, Ponzoni M, O'Brien P, Rubenstein J, Connors JM.

J Clin Oncol. 2005 Apr 1;23(10):2233-9.

2.

Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.

Song MK, Chung JS, Joo YD, Lee SM, Oh SY, Shin DH, Yun EY, Kim SG, Seol YM, Shin HJ, Choi YJ, Cho GJ.

J Neurooncol. 2011 Sep;104(3):825-31. doi: 10.1007/s11060-011-0555-z. Epub 2011 Mar 6. Erratum in: J Neurooncol. 2011 Sep;104(3):833.

PMID:
21380743
3.

[Primary central nervous system lymphoma--a report of 32 cases with literature review].

Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):476-80. Review. Chinese.

PMID:
16613684
4.

Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Abla O, Weitzman S, Blay JY, O'Neill BP, Abrey LE, Neuwelt E, Doolittle ND, Baehring J, Pradhan K, Martin SE, Guerrera M, Shah S, Ghesquieres H, Silver M, Betensky RA, Batchelor T.

Clin Cancer Res. 2011 Jan 15;17(2):346-52. doi: 10.1158/1078-0432.CCR-10-1161. Epub 2011 Jan 11.

5.

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience.

Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, Calderoni A, Rossi A, Vavassori V, Conconi A, Devizzi L, Berger F, Ponzoni M, Borisch B, Tinguely M, Cerati M, Milani M, Orvieto E, Sanchez J, Chevreau C, Dell'Oro S, Zucca E, Cavalli F.

J Clin Oncol. 2003 Jan 15;21(2):266-72.

PMID:
12525518
6.

Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.

Shibamoto Y, Ogino H, Hasegawa M, Suzuki K, Nishio M, Fujii T, Kato E, Ishihara S, Sougawa M, Kenjo M, Kawamura T, Hayabuchi N.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):809-13.

PMID:
15936564
7.

Phase II multicenter study of brief single-agent methotrexate followed by irradiation in primary CNS lymphoma.

O'Brien P, Roos D, Pratt G, Liew K, Barton M, Poulsen M, Olver I, Trotter G.

J Clin Oncol. 2000 Feb;18(3):519-26.

PMID:
10653867
8.

Results of treatment of 112 cases of primary CNS lymphoma.

Yamanaka R, Morii K, Shinbo Y, Homma J, Sano M, Tsuchiya N, Yajima N, Tamura T, Hondoh H, Takahashi H, Kakuma T, Tanaka R.

Jpn J Clin Oncol. 2008 May;38(5):373-80. doi: 10.1093/jjco/hyn027. Epub 2008 Apr 15.

9.

Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.

Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E; Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.

Cancer. 2006 Jun 15;106(12):2540-6.

10.

A multicenter study of treatment of primary CNS lymphoma.

Ferreri AJ, Reni M, Pasini F, Calderoni A, Tirelli U, Pivnik A, Aondio GM, Ferrarese F, Gomez H, Ponzoni M, Borisch B, Berger F, Chassagne C, Iuzzolino P, Carbone A, Weis J, Pedrinis E, Motta T, Jouvet A, Barbui T, Cavalli F, Blay JY.

Neurology. 2002 May 28;58(10):1513-20.

PMID:
12034789
11.

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.

Kim SJ, Oh SY, Kim JS, Kim H, Lee GW, Won JH, Shin HJ, Yang DH, Choi CW, Park J, Kim WS, Suh C.

Ann Hematol. 2011 May;90(5):539-46. doi: 10.1007/s00277-010-1104-0. Epub 2010 Oct 20.

PMID:
20960190
12.

International study on low-grade primary central nervous system lymphoma.

Jahnke K, Korfel A, O'Neill BP, Blay JY, Abrey LE, Martus P, Poortmans PM, Shenkier TN, Batchelor TT, Neuwelt EA, Raizer JJ, Schiff D, Pels H, Herrlinger U, Stein H, Thiel E.

Ann Neurol. 2006 May;59(5):755-62.

PMID:
16586496
13.

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors.

Jahnke K, Thiel E, Martus P, Herrlinger U, Weller M, Fischer L, Korfel A; German Primary Central Nervous System Lymphoma Study Group.

J Neurooncol. 2006 Nov;80(2):159-65. Epub 2006 May 13.

PMID:
16699873
14.

Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.

Kiewe P, Fischer L, Martus P, Thiel E, Korfel A.

Cancer. 2008 Apr 15;112(8):1812-20. doi: 10.1002/cncr.23377.

15.

Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Grimm SA, Pulido JS, Jahnke K, Schiff D, Hall AJ, Shenkier TN, Siegal T, Doolittle ND, Batchelor T, Herrlinger U, Neuwelt EA, Laperriere N, Chamberlain MC, Blay JY, Ferreri AJ, Omuro AM, Thiel E, Abrey LE.

Ann Oncol. 2007 Nov;18(11):1851-5. Epub 2007 Sep 5.

16.

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.

Arkenau HT, Chong G, Cunningham D, Watkins D, Agarwal R, Sirohi B, Trumper M, Norman A, Wotherspoon A, Horwich A.

Ann Oncol. 2007 Mar;18(3):541-5. Epub 2006 Dec 12.

17.
19.

Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.

Gerber DE, Grossman SA, Batchelor T, Ye X.

Cancer Chemother Pharmacol. 2007 May;59(6):817-23. Epub 2006 Sep 14.

PMID:
16972068
20.

Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.

Doolittle ND, Abrey LE, Shenkier TN, Tali S, Bromberg JE, Neuwelt EA, Soussain C, Jahnke K, Johnston P, Illerhaus G, Schiff D, Batchelor T, Montoto S, Kraemer DF, Zucca E.

Blood. 2008 Feb 1;111(3):1085-93. Epub 2007 Oct 25.

Items per page

Supplemental Content

Write to the Help Desk